Viral Immunology, Vaccines, and Antivirals
A section of Viruses (ISSN 1999-4915).
Section Information
- acquired resistance and evolution
- regulatory/societal/legislation aspects
- immune system stimulation
- limitations of vaccines
- new developments and the future
- natural antivirals and their uses
- viral infections
- differences between antivirals and antibiotics in health care
- antiviral use in children
- immunology/animal models
- adverse effects
Editorial Board
Topical Advisory Panel
Click here to see the Section Topical Advisory Panel of "Viral Immunology, Vaccines, and Antivirals".
Special Issues
Following special issues within this section are currently open for submissions:
- Rotaviruses and Rotavirus Vaccines: 2nd Edition (Deadline: 31 August 2026)
- Therapeutic Antibodies in HIV (Deadline: 31 August 2026)
- Contribution of the Host Cell Integrated Stress Response (ISR) to Immunopathogenesis of Human RNA Viral Infections (Deadline: 31 August 2026)
- Mechanisms of Herpesvirus Resistance (Deadline: 1 September 2026)
- Innate Immune Sensing of Viruses (Deadline: 30 September 2026)
- Filoviruses: Ebola and Marburg—Virus–Host Interactions: New Insights into Viral Pathogenesis and Therapeutic Advances (Deadline: 30 September 2026)
- Immune Evasion and Viral Carcinogenesis (Deadline: 30 September 2026)
- Recent Advances in Anti-HCV, Anti-HBV and Anti-Flavivirus Agents, 2nd Edition (Deadline: 31 October 2026)
- Signaling Pathways in Viral Infection and Antiviral Immunity 2026 (Deadline: 31 October 2026)
- The Development of Universal Influenza Vaccines (Deadline: 31 October 2026)
- Early ART Initiation: Impacts on Viral Dynamics and Clinical Outcomes (Deadline: 31 October 2026)
- Maternal-Fetal Interaction in the Antiviral Response (Deadline: 18 November 2026)
- 2nd Edition: How to Adjust the Action Steps for Achieving the Global Hepatitis Virus (HBV/HCV/HDV) Elimination Targets? (Deadline: 30 November 2026)
- Natural, Semisynthetic, and Synthetic Antiviral Drugs: Combating Emerging and Re-Emerging Viral Threats (Deadline: 30 November 2026)
- Development of Diagnostics and Therapeutic Interventions for Viral Infections of the Central Nervous System (Deadline: 30 November 2026)
- Viral Immune Imprinting and Vaccine Design (Deadline: 30 November 2026)
- Advanced Antiviral Nanomaterials and Nanocomposites (Deadline: 20 December 2026)
- Gene Therapy in the Fight Against Viral Infections and Related Diseases: Innovations, Challenges and Future Perspectives (Deadline: 25 December 2026)
- Advances in Respiratory Viruses Research: From Basic Studies to Public Health (Deadline: 30 December 2026)
- Roles of Macrophages in Viral Infections, 2nd Edition (Deadline: 31 December 2026)
- Basophils and Mast Cells in Respiratory Viral Pathogenesis (Deadline: 31 December 2026)
- Viral Strategies to Regulate Host Immunity or Signal Pathways, 2nd Edition (Deadline: 31 December 2026)
- Broadly Neutralizing Antibodies and Next-Generation Vaccines Against Emerging and Re-Emerging Viruses (Deadline: 31 December 2026)
- Rabies Virus: Treatment and Prevention—2nd Edition (Deadline: 31 December 2026)
- Antiviral Resistance Mutations, 2nd Edition (Deadline: 31 December 2026)
- Advances in Measles Virus Research, Vaccine Development and Vaccination Strategies (Deadline: 31 December 2026)
- Nanotechnology-Driven Strategy Against Viral Infections (Deadline: 31 December 2026)
- Oncolytic Virotherapy 2026 (Deadline: 31 December 2026)
- Oncolytic Virus Engineering for Tumor Immunotherapy (Deadline: 31 December 2026)
- Vaccines and Therapeutics Against Orthoflaviviruses (Deadline: 28 January 2027)
- Chikungunya Virus in Viral Immunology and Vaccine Research (Deadline: 31 January 2027)
- Intrinsic Immunity vs. Viral Antagonism: Which One Bites the Dust? (Deadline: 31 January 2027)
- Adenovirus Cell and Immune Interactions 2026 (Deadline: 31 January 2027)
- Viral Immune Evasion and Host Defense: Mechanisms and Therapeutic Targets (Deadline: 31 January 2027)
- Antiviral Protease Inhibitors (Deadline: 31 January 2027)
- Novel Antiviral Strategies: Direct-Acting and Host-Directed Antivirals (Deadline: 28 February 2027)
- Immune Responses and Antiviral Strategies Against Emerging RNA Viruses (Deadline: 28 February 2027)
- Targeted Inhibition of Viral Proteins (Deadline: 28 February 2027)
- Antiviral Drugs and Biologics Targeting HIV: Drug Resistance to Newer Treatment and Pre-Exposure Prophylaxis (PrEP) Options: 2nd Edition (Deadline: 28 February 2027)
- Interferon-Stimulated Genes in Antiviral Immunity (Deadline: 28 February 2027)
- Immune Mechanisms Against Respiratory Viral Pathogens (Deadline: 28 February 2027)
- Acute and Persistent Immune Responses to Respiratory Infections and Vaccines—Mucosal and Systemic (Deadline: 28 February 2027)
- Immune Metabolism and Autophagy in Chronic Viral Infections (Deadline: 28 February 2027)
- Broad-Spectrum Antiviral Strategies Against Emerging and Re-Emerging Viral Diseases (Deadline: 27 March 2027)
- Druggable Targets for Antiviral Intervention (Deadline: 31 March 2027)
- Highly Pathogenic Pathogens: Animal Models of Infection and Vaccine Research (Deadline: 31 March 2027)
- Nasal Immunity Against Virus Infection (Deadline: 31 March 2027)
- Antiviral Agents and Peptides: Discovery, Mechanisms, and Therapeutic Applications (Deadline: 30 April 2027)
- Innate and Mucosal Immunity Against Viral Infections (Deadline: 30 April 2027)
- Recent Advances in Antiviral Natural Products, 2nd Edition (Deadline: 30 April 2027)
- Viral Immunogenicity and Design of Vaccines (Deadline: 1 May 2027)
- Virus–Host Protein Interactions, 2nd Edition (Deadline: 31 May 2027)
- Viral Aerosol Transmission, Host Environmental Exposures, and Antiviral Intervention Strategies (Deadline: 31 May 2027)
- Rational Antiviral Therapy: Targeting Viral and Host Determinants for Optimized Treatment (Deadline: 30 June 2027)
- Structure, Function, and Inhibition of HIV Proteins: Advances in Therapeutic Targets and Drug Discovery (Deadline: 31 July 2027)
- Immunity in Persistent Viral Infection and AI Guided Antiviral Drug Design (Deadline: 30 September 2027)
- Interferon in Viral Pathogenesis: Immune Modulation and Evasion (Deadline: 30 December 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
